Literature DB >> 30415667

The fake unlocked femoral nail: A configuration to avoid in stable pertrochanteric femur fractures.

Claudio Maria Mori1, Giovanni Vicenti1, Massimiliano Carrozzo2, Girolamo Picca1, Davide Bizzoca1, Andrea Leone1, Arcangelo Morizio1, Giuseppe Solarino1, Biagio Moretti1.   

Abstract

BACKGROUND: Intramedullary unlocked nailing is a safe and used treatment for stable pertrocantheric fractures. Due to the femoral anterior bow of the shaft or a wrong entry point, the distal tip of the nail can be impinging the anterior cortex. This type of situation can compromise the function of the nail, leading to nonunion of the fracture, and cut-out. The aim of this study was to assess the relationship between nail impingement of the anterior cortex of the femur and cut-out and nonunion incidence in patients with pertrochanteric stable fracture treated with an IM nail in an unlocked configuration.
MATERIAL AND METHODS: A retrospective study based on medical records and imaging from the archives of our Level I academic medical center was conducted. The study included patients with proximal femoral fractures treated with short cephalomedullary nails between January 2012 and May 2015. The data collected were analyzed to a possible correlation with the healing time and occurrence of nonunion and cut-out.
RESULTS: The study population counted 429 cases. Applying the inclusion criteria the final series was composed of 169 patients: 112 females (66.73%) and 57 males (33.27%), with a mean age of 81.23 years (range: 67-93 years). Distal tip impingement was observed in 22 cases (13.02%). In total 16 (9.47%) postoperative complications were recorded: 8 non-union and 7 cut-outs. Consolidation was registered in 153 cases and the fracture healing time averaged 14.4 ± 3.8 weeks (range, 11-24 weeks). The cortical impingement was correlated with nonunion and cut-out (p < 0.001) Logistic regression analysis revealed jamming sign significantly affected the fracture healing time (p < 0.001).
CONCLUSION: The occurrence of cut-out and nonunion after cephalomedullary nailing of stable pertrochanteric fractures appear to be correlated to the presence of the cortical impingement. For this reason, the fake unlocked femoral nail with the cortical impingement is a configuration to avoid in stable pertrochanteric femur fractures.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complications; Cut-out; Distal locking; Intramedullary nail; Nonunion; Pertrochanteric fractures

Mesh:

Year:  2018        PMID: 30415667     DOI: 10.1016/j.injury.2018.09.057

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  4 in total

1.  Distal locked versus unlocked intramedullary nailing for stable intertrochanteric fractures, a systematic review and meta-analysis.

Authors:  Yan-Hui Li; Tiecheng Yu; Wenjing Shao; Yanwei Liu; Dong Zhu; Lei Tan
Journal:  BMC Musculoskelet Disord       Date:  2020-07-13       Impact factor: 2.362

2.  Risk Factors for Anterior Cortical Impingement of Short Cephalomedullary Nail in Chinese Elderly Patients with Intertrochanteric Fracture.

Authors:  Shaobo Nie; Ming Li; Jiantao Li; Yanpeng Zhao; Xiang Cui; Gaoxiang Xu; Licheng Zhang; Wei Zhang; Peifu Tang
Journal:  Ther Clin Risk Manag       Date:  2020-06-18       Impact factor: 2.423

3.  Use of the 95-degree angled blade plate with biological and mechanical augmentation to treat proximal femur non-unions: a case series.

Authors:  Giovanni Vicenti; Giuseppe Solarino; Davide Bizzoca; Filippo Simone; Giuseppe Maccagnano; Giacomo Zavattini; Guglielmo Ottaviani; Massimiliano Carrozzo; Claudio Buono; Domenico Zaccari; Biagio Moretti
Journal:  BMC Musculoskelet Disord       Date:  2022-02-28       Impact factor: 2.362

4.  Radiologic predictor of intraoperative lateral wall fractures in treatment of pertrochanteric fractures with cephalomedullary nailing.

Authors:  Jun-Qi Dai; Dongxu Jin; Changqing Zhang; Yi-Gang Huang
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.